Adverse Outcome Pathway on chronic binding of antagonist to N-methyl-D-aspartate receptors during brain development leading to neurodegeneration with impairment in learning and memory in aging:
This AOP links chronic NMDA receptors inhibition during brain development to neurodegeneration in hippocampus and cortex with amyloid plaque deposition and tau hyperphosphorylation, and impairment of learning and memory, which are considered as hallmark of Alzheimer's disease. It makes use of s...
Gespeichert in:
1. Verfasser: | |
---|---|
Weitere Verfasser: | |
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Paris
OECD Publishing
2018
|
Schriftenreihe: | OECD Series on Adverse Outcome Pathways
no.8 |
Schlagworte: | |
Online-Zugang: | Volltext |
Zusammenfassung: | This AOP links chronic NMDA receptors inhibition during brain development to neurodegeneration in hippocampus and cortex with amyloid plaque deposition and tau hyperphosphorylation, and impairment of learning and memory, which are considered as hallmark of Alzheimer's disease. It makes use of some KEs and KERs from AOP 13 and introduces Neuroinflammation as KE, which is involved in several neurodegenerative diseases. This AOP is based on the hypothesis of Landrigan and coworkers (2005) proposing an early origin of neurodegenerative diseases in later life. The chemical initiator used in this AOP for the empirical support is lead (Pb). In adults, cumulative lifetime Pb exposure is also associated with decline in cognition, suggesting that long-term exposure during development or occupational exposure increases the risk to develop neurodegenerative disease. The long latency period between exposure and late-onset of effects gives a very broad life-stage applicability. The gap of knowledge is mainly due to limited quantitative evaluations. |
Beschreibung: | 1 Online-Ressource (104 p.) |
DOI: | 10.1787/95f569ad-en |
Internformat
MARC
LEADER | 00000cam a22000002 4500 | ||
---|---|---|---|
001 | ZDB-13-SOC-061274488 | ||
003 | DE-627-1 | ||
005 | 20231204121031.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210204s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1787/95f569ad-en |2 doi | |
035 | |a (DE-627-1)061274488 | ||
035 | |a (DE-599)KEP061274488 | ||
035 | |a (FR-PaOEC)95f569ad-en | ||
035 | |a (EBP)061274488 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Tschudi-Monnet, Florianne |e VerfasserIn |4 aut | |
245 | 1 | 0 | |a Adverse Outcome Pathway on chronic binding of antagonist to N-methyl-D-aspartate receptors during brain development leading to neurodegeneration with impairment in learning and memory in aging |c Florianne, Tschudi-Monnet and Rex, FitzGerald |
264 | 1 | |a Paris |b OECD Publishing |c 2018 | |
300 | |a 1 Online-Ressource (104 p.) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
490 | 0 | |a OECD Series on Adverse Outcome Pathways |v no.8 | |
520 | |a This AOP links chronic NMDA receptors inhibition during brain development to neurodegeneration in hippocampus and cortex with amyloid plaque deposition and tau hyperphosphorylation, and impairment of learning and memory, which are considered as hallmark of Alzheimer's disease. It makes use of some KEs and KERs from AOP 13 and introduces Neuroinflammation as KE, which is involved in several neurodegenerative diseases. This AOP is based on the hypothesis of Landrigan and coworkers (2005) proposing an early origin of neurodegenerative diseases in later life. The chemical initiator used in this AOP for the empirical support is lead (Pb). In adults, cumulative lifetime Pb exposure is also associated with decline in cognition, suggesting that long-term exposure during development or occupational exposure increases the risk to develop neurodegenerative disease. The long latency period between exposure and late-onset of effects gives a very broad life-stage applicability. The gap of knowledge is mainly due to limited quantitative evaluations. | ||
650 | 4 | |a Environment | |
650 | 4 | |a Social Issues/Migration/Health | |
700 | 1 | |a FitzGerald, Rex |e MitwirkendeR |4 ctb | |
856 | 4 | 0 | |l FWS01 |p ZDB-13-SOC |q FWS_PDA_SOC |u https://doi.org/10.1787/95f569ad-en |3 Volltext |
912 | |a ZDB-13-SOC | ||
912 | |a ZDB-13-SOC | ||
951 | |a BO | ||
912 | |a ZDB-13-SOC | ||
049 | |a DE-863 |
Datensatz im Suchindex
DE-BY-FWS_katkey | ZDB-13-SOC-061274488 |
---|---|
_version_ | 1804748655895248896 |
adam_text | |
any_adam_object | |
author | Tschudi-Monnet, Florianne |
author2 | FitzGerald, Rex |
author2_role | ctb |
author2_variant | r f rf |
author_facet | Tschudi-Monnet, Florianne FitzGerald, Rex |
author_role | aut |
author_sort | Tschudi-Monnet, Florianne |
author_variant | f t m ftm |
building | Verbundindex |
bvnumber | localFWS |
collection | ZDB-13-SOC |
ctrlnum | (DE-627-1)061274488 (DE-599)KEP061274488 (FR-PaOEC)95f569ad-en (EBP)061274488 |
discipline | Wirtschaftswissenschaften |
doi_str_mv | 10.1787/95f569ad-en |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02338cam a22003612 4500</leader><controlfield tag="001">ZDB-13-SOC-061274488</controlfield><controlfield tag="003">DE-627-1</controlfield><controlfield tag="005">20231204121031.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210204s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1787/95f569ad-en</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627-1)061274488</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)KEP061274488</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(FR-PaOEC)95f569ad-en</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EBP)061274488</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Tschudi-Monnet, Florianne</subfield><subfield code="e">VerfasserIn</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Adverse Outcome Pathway on chronic binding of antagonist to N-methyl-D-aspartate receptors during brain development leading to neurodegeneration with impairment in learning and memory in aging</subfield><subfield code="c">Florianne, Tschudi-Monnet and Rex, FitzGerald</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Paris</subfield><subfield code="b">OECD Publishing</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (104 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">OECD Series on Adverse Outcome Pathways</subfield><subfield code="v">no.8</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This AOP links chronic NMDA receptors inhibition during brain development to neurodegeneration in hippocampus and cortex with amyloid plaque deposition and tau hyperphosphorylation, and impairment of learning and memory, which are considered as hallmark of Alzheimer's disease. It makes use of some KEs and KERs from AOP 13 and introduces Neuroinflammation as KE, which is involved in several neurodegenerative diseases. This AOP is based on the hypothesis of Landrigan and coworkers (2005) proposing an early origin of neurodegenerative diseases in later life. The chemical initiator used in this AOP for the empirical support is lead (Pb). In adults, cumulative lifetime Pb exposure is also associated with decline in cognition, suggesting that long-term exposure during development or occupational exposure increases the risk to develop neurodegenerative disease. The long latency period between exposure and late-onset of effects gives a very broad life-stage applicability. The gap of knowledge is mainly due to limited quantitative evaluations.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Environment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Social Issues/Migration/Health</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">FitzGerald, Rex</subfield><subfield code="e">MitwirkendeR</subfield><subfield code="4">ctb</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-13-SOC</subfield><subfield code="q">FWS_PDA_SOC</subfield><subfield code="u">https://doi.org/10.1787/95f569ad-en</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">BO</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
id | ZDB-13-SOC-061274488 |
illustrated | Not Illustrated |
indexdate | 2024-07-16T15:07:20Z |
institution | BVB |
language | English |
open_access_boolean | |
owner | DE-863 DE-BY-FWS |
owner_facet | DE-863 DE-BY-FWS |
physical | 1 Online-Ressource (104 p.) |
psigel | ZDB-13-SOC |
publishDate | 2018 |
publishDateSearch | 2018 |
publishDateSort | 2018 |
publisher | OECD Publishing |
record_format | marc |
series2 | OECD Series on Adverse Outcome Pathways |
spelling | Tschudi-Monnet, Florianne VerfasserIn aut Adverse Outcome Pathway on chronic binding of antagonist to N-methyl-D-aspartate receptors during brain development leading to neurodegeneration with impairment in learning and memory in aging Florianne, Tschudi-Monnet and Rex, FitzGerald Paris OECD Publishing 2018 1 Online-Ressource (104 p.) Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier OECD Series on Adverse Outcome Pathways no.8 This AOP links chronic NMDA receptors inhibition during brain development to neurodegeneration in hippocampus and cortex with amyloid plaque deposition and tau hyperphosphorylation, and impairment of learning and memory, which are considered as hallmark of Alzheimer's disease. It makes use of some KEs and KERs from AOP 13 and introduces Neuroinflammation as KE, which is involved in several neurodegenerative diseases. This AOP is based on the hypothesis of Landrigan and coworkers (2005) proposing an early origin of neurodegenerative diseases in later life. The chemical initiator used in this AOP for the empirical support is lead (Pb). In adults, cumulative lifetime Pb exposure is also associated with decline in cognition, suggesting that long-term exposure during development or occupational exposure increases the risk to develop neurodegenerative disease. The long latency period between exposure and late-onset of effects gives a very broad life-stage applicability. The gap of knowledge is mainly due to limited quantitative evaluations. Environment Social Issues/Migration/Health FitzGerald, Rex MitwirkendeR ctb FWS01 ZDB-13-SOC FWS_PDA_SOC https://doi.org/10.1787/95f569ad-en Volltext |
spellingShingle | Tschudi-Monnet, Florianne Adverse Outcome Pathway on chronic binding of antagonist to N-methyl-D-aspartate receptors during brain development leading to neurodegeneration with impairment in learning and memory in aging Environment Social Issues/Migration/Health |
title | Adverse Outcome Pathway on chronic binding of antagonist to N-methyl-D-aspartate receptors during brain development leading to neurodegeneration with impairment in learning and memory in aging |
title_auth | Adverse Outcome Pathway on chronic binding of antagonist to N-methyl-D-aspartate receptors during brain development leading to neurodegeneration with impairment in learning and memory in aging |
title_exact_search | Adverse Outcome Pathway on chronic binding of antagonist to N-methyl-D-aspartate receptors during brain development leading to neurodegeneration with impairment in learning and memory in aging |
title_full | Adverse Outcome Pathway on chronic binding of antagonist to N-methyl-D-aspartate receptors during brain development leading to neurodegeneration with impairment in learning and memory in aging Florianne, Tschudi-Monnet and Rex, FitzGerald |
title_fullStr | Adverse Outcome Pathway on chronic binding of antagonist to N-methyl-D-aspartate receptors during brain development leading to neurodegeneration with impairment in learning and memory in aging Florianne, Tschudi-Monnet and Rex, FitzGerald |
title_full_unstemmed | Adverse Outcome Pathway on chronic binding of antagonist to N-methyl-D-aspartate receptors during brain development leading to neurodegeneration with impairment in learning and memory in aging Florianne, Tschudi-Monnet and Rex, FitzGerald |
title_short | Adverse Outcome Pathway on chronic binding of antagonist to N-methyl-D-aspartate receptors during brain development leading to neurodegeneration with impairment in learning and memory in aging |
title_sort | adverse outcome pathway on chronic binding of antagonist to n methyl d aspartate receptors during brain development leading to neurodegeneration with impairment in learning and memory in aging |
topic | Environment Social Issues/Migration/Health |
topic_facet | Environment Social Issues/Migration/Health |
url | https://doi.org/10.1787/95f569ad-en |
work_keys_str_mv | AT tschudimonnetflorianne adverseoutcomepathwayonchronicbindingofantagonisttonmethyldaspartatereceptorsduringbraindevelopmentleadingtoneurodegenerationwithimpairmentinlearningandmemoryinaging AT fitzgeraldrex adverseoutcomepathwayonchronicbindingofantagonisttonmethyldaspartatereceptorsduringbraindevelopmentleadingtoneurodegenerationwithimpairmentinlearningandmemoryinaging |